FTC Targets Supplement Firm In Administrative Proceeding After Contempt Complaint Fails

Federal Judge Says Settlement Stipulation Against ‘Treats Disease’ Claims Is Ambiguous

A ruling in Maine federal court questions whether FTC could show firms made claims a product labeled as a supplement “cures, mitigates, or treats any disease." But agency's administrative complaint includes the same phrase as a stipulation among the penalties it would order.

More from Compliance

More from Policy & Regulation